Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1

被引：0
|
作者：
François Bertucci
Anthony Gonçalves
机构：
[1] Institut Paoli-Calmettes,Department of Medical Oncology
[2] Department of Molecular Oncology,Faculty of Medicine
[3] Centre de Recherche en Cancérologie de Marseille (CRCM),undefined
[4] CNRS U7258,undefined
[5] INSERM U1068,undefined
[6] Aix-Marseille University,undefined
来源：
Current Oncology Reports | 2017年 / 19卷
关键词：
Breast cancer; Expression; Immune response; Monoclonal antibodies; PD-1; PD-L1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] PD-1/PD-L1 Axis in Lung Cancer
    Santini, Fernando C.
    Hellmann, Matthew D.
    CANCER JOURNAL, 2018, 24 (01): : 15 - 19
  • [42] PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment
    Parvez, Adil
    Choudhary, Furqan
    Mudgal, Priyal
    Khan, Rahila
    Qureshi, Kamal A.
    Farooqi, Humaira
    Aspatwar, Ashok
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [43] Intelligent delivery system targeting PD-1/PD-L1 pathway for cancer immunotherapy
    Liu, Ning
    Zhang, Renshuai
    Shi, Qiang
    Jiang, Hongfei
    Zhou, Qihui
    BIOORGANIC CHEMISTRY, 2023, 136
  • [44] Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy
    Lu, Jing
    Lee-Gabel, Linda
    Nadeau, Michelle C.
    Ferencz, Thomas M.
    Soefje, Scott A.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2015, 21 (06) : 451 - 467
  • [45] Contemporary clinical trials in pancreatic cancer immunotherapy targeting PD-1 and PD-L1
    Nagaraju, Ganji Purnachandra
    Malla, Rama Rao
    Basha, Riyaz
    Motofei, Ion G.
    SEMINARS IN CANCER BIOLOGY, 2022, 86 : 616 - 621
  • [46] Identifying Rational Candidates for Immunotherapy Targeting PD-1/PD-L1 in Cervical Cancer
    Kim, Miseon
    Kim, Hyojin
    Suh, Dong Hoon
    Kim, Kidong
    Kim, Haeryoung
    Kim, Yong Beom
    No, Jae Hong
    ANTICANCER RESEARCH, 2017, 37 (09) : 5087 - 5094
  • [47] PD-L1/PD-1 axis as a potent therapeutic target in breast cancer
    Bastaki, Shima
    Irandoust, Mahzad
    Ahmadi, Armin
    Hojjat-Farsangi, Mohammad
    Ambrose, Patrick
    Hallaj, Shahin
    Edalati, Mahdi
    Ghalamfarsa, Ghasem
    Azizi, Gholamreza
    Yousefi, Mehdi
    Chalajour, Hengameh
    Jadidi-Niaragh, Farhad
    LIFE SCIENCES, 2020, 247
  • [48] Engineered nanomedicines block the PD-1/PD-L1 axis for potentiated cancer immunotherapy
    Li, Jun-hao
    Huang, Lu-jia
    Zhou, Hui-ling
    Shan, Yi-ming
    Chen, Fang-min
    Lehto, Vesa-Pekka
    Xu, Wu-jun
    Luo, Li-qiang
    Yu, Hai-jun
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (11) : 2749 - 2758
  • [49] Engineered nanomedicines block the PD-1/PD-L1 axis for potentiated cancer immunotherapy
    Jun-hao Li
    Lu-jia Huang
    Hui-ling Zhou
    Yi-ming Shan
    Fang-min Chen
    Vesa-Pekka Lehto
    Wu-jun Xu
    Li-qiang Luo
    Hai-jun Yu
    Acta Pharmacologica Sinica, 2022, 43 : 2749 - 2758
  • [50] Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapy
    Bingshan Liu
    Yongping Song
    Delong Liu
    Journal of Hematology & Oncology, 10
12345